» Related Searches: cancer risk, prostate cancer, cancer patients, cancer drug, breast cancer research
Results 71 to 80 of 645 
… cancer could go on to have children, thanks to a new option that avoids a
hysterectomy. The researchers focussed on women of childbearing age and found that if a
"fertility-sparing … 



CuraGen Corporation and TopoTarget have initiated patient dosing in a phase II trial
evaluating the antitumor activity of PXD101 in the treatment of ovarian cancer … 



Synta Pharmaceuticals has said its oncology drug candidate, STA-4783, has been granted
fast track designation by the FDA for the treatment of metastatic melanoma, a serious type
of skin cancer … 
Heat shock protein 90 (Hsp90) is an emerging therapeutic target of interest for the
treatment of cancer. Its role in … ![[Medical_Sciences] Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90](/i/v.gif)



A MAJOR cancer vaccine that can trigger sufferers' immune systems to recognise and
attack diseased cells is to be tested in Manchester … 



Aeterna Zentaris has presented detailed positive phase II results in hormone-dependent,
inoperable prostate cancer for its compound ozarelix … 



Title: Firefighters at High Risk for Cancer Category: Health News Created: 11/11/2006
2:05:00 AM Last Editorial Review: 11/13/2006 … 



The silver lining - if red meat does indeed increase the risk of breast cancer - is
that the cure would be simple: Just eat less meat … 
… cancer, and one of the strongest is inheritance of a gene variant, GSTM1
positive, which is more efficient than another allele type of the GSTM1 gene at
detoxifying carcinogens … 



… cancer and other major health threats, announced that a leading independent
research firm, First Berlin Equity Research, has issued an updated research report with a
"Buy" rating, and a speculative … 


